##common.search##
##search.searchResults##
-
THE SIGNIFICANCE OF ECHOCARDIOGRAPHY IN DETECTING CONGENITAL HEART DEFECTS IN THE PRENATAL AND POSTNATAL PERIODS
Congenital heart defects (CHDs) represent the most common type of congenital malformations and remain a leading cause of neonatal morbidity and mortality worldwide. Early and accurate diagnosis is crucial for improving clinical outcomes and reducing complications. This review article evaluates the diagnostic value, capabilities, and limitations of echocardiography in detecting CHDs during both prenatal and postnatal periods.
Fetal echocardiography has become an essential component of prenatal screening, allowing reliable identification of cardiac anomalies as early as 18–22 weeks of gestation, with even earlier assessments possible using advanced technologies. It plays a pivotal role in risk stratification, prenatal counseling, and perinatal management planning. The integration of artificial intelligence into fetal echocardiography has further enhanced diagnostic accuracy, improving sensitivity and specificity while reducing operator dependency.
In the postnatal period, transthoracic echocardiography remains the first-line diagnostic modality for evaluating suspected CHDs. Advanced techniques, including Doppler imaging, 3D echocardiography, transesophageal echocardiography, and point-of-care ultrasound, provide comprehensive anatomical and functional assessment, guiding clinical decision-making and surgical planning.
In conclusion, echocardiography remains the cornerstone imaging modality for the diagnosis and management of CHDs across prenatal and postnatal stages. Expanding access to advanced echocardiographic techniques, improving specialist training, and integrating modern technologies such as artificial intelligence are essential for optimizing outcomes, particularly in developing healthcare systems.